Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$5.50
+0.2%
$4.58
$3.42
$7.20
$309.18M1.941.55 million shs853,574 shs
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
$5.43
+0.2%
$5.46
$3.79
$14.60
$272.06M-0.921.47 million shs690,836 shs
InterCure Ltd. stock logo
INCR
InterCure
$1.55
+0.1%
$1.45
$1.17
$3.32
$70.64M1.2528,742 shs2,826 shs
Neurogene Inc. stock logo
NGNE
Neurogene
$17.28
-4.2%
$13.62
$6.88
$74.49
$246.45M1.56242,255 shs110,750 shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
+0.18%+7.21%+25.00%-6.62%-19.71%
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
+0.18%+1.50%+13.48%-53.31%-48.68%
InterCure Ltd. stock logo
INCR
InterCure
+0.45%+0.65%+5.80%-5.49%-50.00%
Neurogene Inc. stock logo
NGNE
Neurogene
-4.21%-3.95%+11.92%-0.46%-46.67%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.752 of 5 stars
0.02.00.00.03.80.80.6
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
1.9417 of 5 stars
3.51.00.00.02.61.70.6
InterCure Ltd. stock logo
INCR
InterCure
N/AN/AN/AN/AN/AN/AN/AN/A
Neurogene Inc. stock logo
NGNE
Neurogene
2.3639 of 5 stars
4.40.00.00.02.51.70.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
3.67
Strong BuyN/AN/A
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
3.00
Buy$21.00286.74% Upside
InterCure Ltd. stock logo
INCR
InterCure
0.00
N/AN/AN/A
Neurogene Inc. stock logo
NGNE
Neurogene
2.71
Moderate Buy$44.60158.10% Upside

Current Analyst Ratings Breakdown

Latest INCR, ACB, CADL, and NGNE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/20/2025
Neurogene Inc. stock logo
NGNE
Neurogene
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$16.00 ➝ $22.00
5/16/2025
Neurogene Inc. stock logo
NGNE
Neurogene
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
5/16/2025
Neurogene Inc. stock logo
NGNE
Neurogene
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Neutral$38.00 ➝ $24.00
5/13/2025
Neurogene Inc. stock logo
NGNE
Neurogene
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$50.00 ➝ $45.00
4/14/2025
Neurogene Inc. stock logo
NGNE
Neurogene
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$45.00 ➝ $16.00
4/11/2025
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$19.00 ➝ $19.00
3/25/2025
Neurogene Inc. stock logo
NGNE
Neurogene
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$38.00
3/25/2025
Neurogene Inc. stock logo
NGNE
Neurogene
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
3/25/2025
Neurogene Inc. stock logo
NGNE
Neurogene
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$55.00 ➝ $50.00
3/14/2025
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$19.00 ➝ $19.00
2/26/2025
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $25.00
(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$320.81M0.96$0.21 per share26.35$8.18 per share0.67
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
$120K2,267.16N/AN/A$0.44 per share12.34
InterCure Ltd. stock logo
INCR
InterCure
$238.85M0.30N/AN/A$2.72 per share0.57
Neurogene Inc. stock logo
NGNE
Neurogene
$925K266.43N/AN/A$14.51 per share1.19
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
-$48.62M$0.05110.0212.50N/A0.42%0.59%0.42%6/19/2025 (Estimated)
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
-$37.94M-$1.34N/AN/AN/AN/A-629.29%-173.39%8/12/2025 (Estimated)
InterCure Ltd. stock logo
INCR
InterCure
-$16.83MN/A0.00N/AN/AN/AN/AN/A
Neurogene Inc. stock logo
NGNE
Neurogene
-$36.32M-$4.35N/AN/AN/AN/A-32.81%-27.96%8/8/2025 (Estimated)

Latest INCR, ACB, CADL, and NGNE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/19/2025Q4 2025
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
$0.11N/AN/AN/A$88.85 millionN/A
5/13/2025Q1 2025
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
-$0.24$0.13+$0.37$0.13N/AN/A
5/9/2025Q1 2025
Neurogene Inc. stock logo
NGNE
Neurogene
-$1.05-$1.08-$0.03-$1.08N/AN/A
3/24/2025Q4 2024
Neurogene Inc. stock logo
NGNE
Neurogene
-$1.04-$0.99+$0.05-$0.99N/A$0.93 million
3/13/2025Q4 2024
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
-$0.23-$0.40-$0.17-$0.40N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
N/AN/AN/AN/AN/A
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
N/AN/AN/AN/AN/A
InterCure Ltd. stock logo
INCR
InterCure
N/AN/AN/AN/AN/A
Neurogene Inc. stock logo
NGNE
Neurogene
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.07
3.30
1.60
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
N/A
1.18
1.18
InterCure Ltd. stock logo
INCR
InterCure
0.15
1.78
1.15
Neurogene Inc. stock logo
NGNE
Neurogene
N/A
9.09
9.09

Institutional Ownership

CompanyInstitutional Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
47.63%
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
13.93%
InterCure Ltd. stock logo
INCR
InterCure
8.34%
Neurogene Inc. stock logo
NGNE
Neurogene
52.37%

Insider Ownership

CompanyInsider Ownership
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
0.01%
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
16.60%
InterCure Ltd. stock logo
INCR
InterCure
0.24%
Neurogene Inc. stock logo
NGNE
Neurogene
9.92%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aurora Cannabis Inc. stock logo
ACB
Aurora Cannabis
1,34056.21 million54.85 millionOptionable
Candel Therapeutics, Inc. stock logo
CADL
Candel Therapeutics
6050.10 million18.97 millionOptionable
InterCure Ltd. stock logo
INCR
InterCure
35045.57 million45.46 millionOptionable
Neurogene Inc. stock logo
NGNE
Neurogene
9014.26 million13.38 millionOptionable

Recent News About These Companies

Neurogene (NASDAQ:NGNE) Cut to "Neutral" at Robert W. Baird
Baird Downgrades Neurogene (NGNE)
What is HC Wainwright's Forecast for Neurogene Q2 Earnings?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Aurora Cannabis stock logo

Aurora Cannabis NASDAQ:ACB

$5.50 +0.01 (+0.18%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$5.49 -0.01 (-0.18%)
As of 05/23/2025 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Candel Therapeutics stock logo

Candel Therapeutics NASDAQ:CADL

$5.43 +0.01 (+0.18%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$5.53 +0.10 (+1.92%)
As of 05/23/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. It develops CAN-2409, which is in Phase II clinical trials for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. The company also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent high-grade glioma. It also develops the?enLIGHTEN Discovery Platform, a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.

InterCure stock logo

InterCure NASDAQ:INCR

$1.55 +0.00 (+0.14%)
Closing price 05/23/2025 03:56 PM Eastern
Extended Trading
$1.54 -0.01 (-0.65%)
As of 05/23/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Neurogene stock logo

Neurogene NASDAQ:NGNE

$17.28 -0.76 (-4.21%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$18.35 +1.07 (+6.19%)
As of 05/23/2025 05:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neurogene Inc., a biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 which is packaged in an adeno-associated virus 9 that is in Phase 1/2 clinical trial for the treatment of Rett syndrome; and NGN-101, a conventional gene therapy candidate that is in Phase 1/2 clinical trial to treat CLN5 Batten disease. It has a license agreement with The University of North Carolina, the University of Edinburgh, Virovek, Inc., and Sigma-Aldrich Co. LLC. The company is headquartered in New York, New York.